{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:01:11Z","timestamp":1771012871055,"version":"3.50.1"},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T00:00:00Z","timestamp":1237334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Treatments for mild to moderately severe acne usually combine retinoid and antimicrobial therapy. Recently, the US FDA approved the combination of 1.2% clindamycin (CLIN) and 0.025% tretinoin (RA) in a novel gel formulation for the treatment of mild to moderate acne, based on results from two 12\u2010week, multicenter, double\u2010blind Phase 3 trials in which patients were randomized to four treatment arms: CLIN\/RA, CLIN, RA, and vehicle. The trials studied more than 4500 patients 12\u2003years of age or older. In both trials, CLIN\/RA gel produced significantly greater clinical improvements than vehicle or either monotherapy. CLIN\/RA was safe and well tolerated in both trials and in a 52\u2010week safety follow\u2010up evaluation. The current study is a subgroup analysis that evaluates CLIN\/RA\u2019s effects on acne lesion prevalence in 12\u2010 to 18\u2010year\u2010old patients with mild to severe baseline acne severity. CLIN\/RA significantly reduced the number of inflammatory, noninflammatory, and total acne lesions after 12\u2003weeks of treatment (p\u2003\u2264\u20030.004) in 1,710 patients aged 12 to 18\u2003years. Relatively greater improvements were seen following CLIN\/RA treatment compared to CLIN or RA monotherapy, or the vehicle gel beginning as early as 2\u2003weeks following treatment initiation. This novel CLIN\/RA gel for treating acne is tolerable and safe and offers clinicians and teen aged patients a new and efficacious intervention for acne vulgaris. \u2028 [Abstract amended after online publication date June 8, 2009]<\/jats:p>","DOI":"10.1111\/j.1525-1470.2008.00862.x","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T09:12:04Z","timestamp":1237367524000},"page":"257-261","source":"Crossref","is-referenced-by-count":17,"title":["A Novel Gel Formulation of 0.25% Tretinoin and 1.2% Clindamycin Phosphate: Efficacy in Acne Vulgaris Patients Aged 12 to 18 Years"],"prefix":"10.1111","volume":"26","author":[{"given":"Lawrence F.","family":"Eichenfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Wortzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,6,10]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01154-X"},{"key":"e_1_2_7_4_2","first-page":"1","article-title":"Psychosocial impact of acne vulgaris: evaluating the evidence","volume":"9","author":"Tan JK","year":"2004","journal-title":"Skin Therapy Lett"},{"key":"e_1_2_7_5_2","first-page":"503","article-title":"Acne and acne scarring \u2013 the case for active and early intervention","volume":"35","author":"Goodman G","year":"2006","journal-title":"Aust Fam Physician"},{"key":"e_1_2_7_6_2","first-page":"607","article-title":"Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris","volume":"6","author":"Schlessinger J","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01152-6"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.046"},{"key":"e_1_2_7_9_2","first-page":"151","article-title":"A novel gel formulation of clindamycin phosphate\/tretinoin is not associated with acne flaring","volume":"82","author":"Leyden J","year":"2008","journal-title":"Cutis"},{"key":"e_1_2_7_10_2","first-page":"358","article-title":"Safety of a novel gel formulation of tretinoin 0.025% and clindamycin phosphate 1.2%: results from a 52\u2010week open\u2010label study","volume":"82","author":"Kircik L","year":"2008","journal-title":"Cutis"},{"issue":"2","key":"e_1_2_7_11_2","first-page":"AB21","article-title":"Unique aqueous gel formulation results in reduced risk of tretinoin\u2010induced irritation bioassay","volume":"26","author":"Plott RT","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_7_12_2","first-page":"662","article-title":"Updates & perspectives on management of common dermatologic disorders","volume":"6","author":"Del Rosso JQ","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_7_13_2","volume-title":"Ziana\u00ae (clindamycin phosphate 1.2% and tretinoin 0.025%) gel [package insert]"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2008.00862.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1470.2008.00862.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T21:21:27Z","timestamp":1697145687000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2008.00862.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1525-1470.2008.00862.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2008.00862.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}